COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
Pharmacotherapy optimization in patients with arterial hypertension and gout is very important. Achievement of the target blood pressure levels is possible with the use of combinations of effective antihypertensive drugs with neutral metabolic profile and safety, in particular a combination of valsa...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ab84b34c4d344ea5a3d9710b61fc14b3 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a O. V. Dralova |e author |
| 700 | 1 | 0 | |a M. L. Maksimov |e author |
| 245 | 0 | 0 | |a COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) |
| 260 | |b Столичная издательская компания, |c 2016-01-01T00:00:00Z. | ||
| 500 | |a 1819-6446 | ||
| 500 | |a 2225-3653 | ||
| 500 | |a 10.20996/1819-6446-2011-7-4-468-472 | ||
| 520 | |a Pharmacotherapy optimization in patients with arterial hypertension and gout is very important. Achievement of the target blood pressure levels is possible with the use of combinations of effective antihypertensive drugs with neutral metabolic profile and safety, in particular a combination of valsartan, amlodipine and aliskiren. Clinical case of this combination use in patient with arterial hypertension and gout is presented. | ||
| 546 | |a EN | ||
| 546 | |a RU | ||
| 690 | |a arterial hypertension | ||
| 690 | |a gout | ||
| 690 | |a valsartan | ||
| 690 | |a amlodipine | ||
| 690 | |a aliskiren | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Diseases of the circulatory (Cardiovascular) system | ||
| 690 | |a RC666-701 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Рациональная фармакотерапия в кардиологии, Vol 7, Iss 4, Pp 468-472 (2016) | |
| 787 | 0 | |n https://www.rpcardio.online/jour/article/view/863 | |
| 787 | 0 | |n https://doaj.org/toc/1819-6446 | |
| 787 | 0 | |n https://doaj.org/toc/2225-3653 | |
| 856 | 4 | 1 | |u https://doaj.org/article/ab84b34c4d344ea5a3d9710b61fc14b3 |z Connect to this object online. |